BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35130630)

  • 1. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs.
    Li F; Song C; Zhang Y; Wu D
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):12-24. PubMed ID: 35130630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Ligand Binding Domain Dynamics in the NRs Superfamily.
    D'Arrigo G; Autiero I; Gianquinto E; Siragusa L; Baroni M; Cruciani G; Spyrakis F
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains.
    Wu W; Niles EG; Hirai H; LoVerde PT
    BMC Evol Biol; 2007 Feb; 7():27. PubMed ID: 17319953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved surface on the ligand binding domain of nuclear receptors for allosteric control.
    Buzón V; Carbó LR; Estruch SB; Fletterick RJ; Estébanez-Perpiñá E
    Mol Cell Endocrinol; 2012 Jan; 348(2):394-402. PubMed ID: 21878368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of 3696 Nuclear Receptor-Coregulator Interactions: A Resource for Biological and Clinical Discovery.
    Broekema MF; Hollman DAA; Koppen A; van den Ham HJ; Melchers D; Pijnenburg D; Ruijtenbeek R; van Mil SWC; Houtman R; Kalkhoven E
    Endocrinology; 2018 Jun; 159(6):2397-2407. PubMed ID: 29718163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent ligands of nuclear receptors.
    Rajan S; Yoon HS
    Eur J Med Chem; 2023 Dec; 261():115869. PubMed ID: 37857142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding nuclear receptor form and function using structural biology.
    Rastinejad F; Huang P; Chandra V; Khorasanizadeh S
    J Mol Endocrinol; 2013 Dec; 51(3):T1-T21. PubMed ID: 24103914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors.
    Caboni L; Lloyd DG
    Med Res Rev; 2013 Sep; 33(5):1081-118. PubMed ID: 23344935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of nuclear receptor-ligand interactions.
    Greschik H; Moras D
    Curr Top Med Chem; 2003; 3(14):1573-99. PubMed ID: 14683516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of nuclear receptor function: Targeting the protein-DNA interface.
    Veras Ribeiro Filho H; Tambones IL; Mariano Gonçalves Dias M; Bernardi Videira N; Bruder M; Amorim Amato A; Migliorini Figueira AC
    Mol Cell Endocrinol; 2019 Mar; 484():1-14. PubMed ID: 30703486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-canonical modulators of nuclear receptors.
    Tice CM; Zheng YJ
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4157-64. PubMed ID: 27503683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-specific integration of nuclear receptor function at the genome.
    Everett LJ; Lazar MA
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(5):615-29. PubMed ID: 23757177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptor: Structure and function.
    Sar P
    Prog Mol Biol Transl Sci; 2023; 196():209-227. PubMed ID: 36813359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric effects govern nuclear receptor action: DNA appears as a player.
    Gronemeyer H; Bourguet W
    Sci Signal; 2009 Jun; 2(73):pe34. PubMed ID: 19491383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs).
    Moore TW; Mayne CG; Katzenellenbogen JA
    Mol Endocrinol; 2010 Apr; 24(4):683-95. PubMed ID: 19933380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric small molecule modulators of nuclear receptors.
    Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
    Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the repertoire of nuclear receptor binding sites in genomes.
    Cotnoir-White D; Laperrière D; Mader S
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors.
    Wang Z; Benoit G; Liu J; Prasad S; Aarnisalo P; Liu X; Xu H; Walker NP; Perlmann T
    Nature; 2003 May; 423(6939):555-60. PubMed ID: 12774125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor superfamily: A structural perspective.
    Weikum ER; Liu X; Ortlund EA
    Protein Sci; 2018 Nov; 27(11):1876-1892. PubMed ID: 30109749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.